«上一篇/Previous Article|本期目录/Table of Contents|下一篇/Next Article»

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:

2018年第4期

页码:

477-481

栏目:

综述

出版日期:

2018-04-25

文章信息/Info

Title:

Reperfusion strategies in patients with ST-segment elevation myocardial Infarction and multivessel disease

作者:

许晓明¹; 2; 李 超²; 程 康¹; 3; 韩雅玲²

（1.第四军医大学西京医院心血管内科，陕西 西安 710032；2.沈阳军区总医院心血管内科，辽宁 沈阳 110016；3.西安市第三医院心内科，陕西 西安 710018）

Author(s):

XU Xiao-ming¹; 2;  LI Chao²;  CHENG Kang¹; 3;  HAN Ya-ling²

(1.Department of Cardiology, Xijing Hospital, Fourth Militery University Xi’an 710032, Shaanxi, China; 2.Department of Cardiology, Shenyang General Hospital, Shenyang 110016, Liaoning, China; 3.Department of Cardiology, Xi’an Third Hospital, Xi’an 710018,

关键词:

心肌梗死; ST段抬高型; 急性; 冠脉多支病变; 经皮冠状动脉介入治疗

Keywords:

acute ST-segment elevation myocardial infarction;  multi-vessel coronary artery disease;  percutaneous coronary intervention

分类号:

R541.4

DOI:

-

文献标识码:

A

摘要:

急性ST段抬高型心肌梗死（ST-segment elevation myocardial infarction,STEMI）是一种发病率逐年上升的心血管急重症之一，致残、致死率高。40%~65%的STEMI患者存在冠状动脉多支病变（multi-vessel disease,MVD），与单支病变相比，并发MVD的STEMI患者心血管不良事件的发生率明显增加。目前，在不考虑外科干预的情况下，针对STEMI多支病变患者的治疗策略主要有3种：即仅对梗死相关血管（infarct-related artery,IRA）即罪犯血管（culprit vessel）行急诊经皮冠状动脉介入（Percutaneous Coronary Intervention,PCI）治疗（culprit-PCI）、同时对IRA及至少1支非梗死相关血管（non-infarct-related artery,non-IRA）行急诊PCI（MV-PCI）、对IRA行急诊PCI后择期对至少1支non-IRA行PCI（staged-PCI）。由于STEMI多支病变患者non-IRA病理生理状态相对特殊，因此，国内外对non-IRA的处理策略及处理时机存在争议。同时，随着临床新技术及新型口服药物不断发展，STEMI多支病变处理策略也不断完善。本文就STEMI多支病变患者血运重建策略研究进展进行综述。

Abstract:

Acute ST-segment elevation myocardial Infarction (STEMI) is a severe cardiovascular disease with a rapidly increasing morbidity, and often causes adverse outcomes. About 40-65% of patients presenting with STEMI have multi-vessel disease (MVD). Compared with patients with single-vessel disease, the incidence of cardiovascular events in STEMI patients with MVD is much higher. Currently, there are three strategies for the treatment of STEMI patients with MVD when coronary artery bypass grafting is not preferred: percutaneous coronary intervention (PCI) confined to culprit vessel lesions only (culprit-PCI); PCI in which lesions in the culprit vessel as well as≥1 non-infarct-related artery (nonculprit vessel lesion) are treated in the same procedure (MV-PCI); and PCI confined to culprit vessel lesions only, after which ≥1 lesions in nonculprit vessel are treated during planned secondary procedures (staged-PCI). As the pathophysiological status of the STEMI patients with MVD is relatively unique, optimal strategy of the non-infarct-related artery in STEMI patients remains unclear. With the development of advanced techniques and new oral drugs, the treatment of STEMI patients has also been improved. This article reviews the advances of strategies for the treatment of STEMI patients with MVD.

参考文献/References

[1]Anderson JL,Morrow DA.Acute Myocardial Infarction[J].N Engl J Med,2017,376(21):2053-2064.

[2]Reed GW,Rossi JE,Cannon CP.Acute myocardial infarction[J].The Lancet,2017,389(10065):197-210.

[3]Patel MR,Calhoon JH,Dehmer GJ,et al.ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2016 Appropriate Use Criteria for Coronary Revascularization in Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology Appropriate Use Criteria Task Force,American Association for Thoracic Surgery,American Heart Association,American Society of Echocardiography, American Society of Nuclear Cardiology,Society for Cardiovascular Angiography and Interventions,Society of Cardiovascular Computed Tomography,and the Society of Thoracic Surgeons[J].J Am Coll Cardiol,2017,69(5):570-591.

[4]中华医学会心血管病学分会介入心脏病学组,中国医师协会心血管内科医师分会,血栓防治专业委员会,等.中国经皮冠状动脉介入治疗指南(2016)[J].中华心血管病杂志,2016,44(5):382-400.

[5]Manari A,Varani E,Guastaroba P,et al.Long-term outcome in patients with ST segment elevation myocardial infarction and multivessel disease treated with culprit-only,immediate,or staged multivessel percutaneous revascularization strategies:Insights from the REAL registry[J].Catheter Cardiovasc Interv,2014,84(6):912-922.

[6]Engstr MT,Kelb KH,Helqvist S,et al.Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease(DANAMI-3-PRIMULTI):an open-label,randomised controlled trial[J].The Lancet,2015,386(9994):665-671.

[7]Wald DS,Morris JK,Wald NJ,et al.Randomized Trial of Preventive Angioplasty in Myocardial Infarction[J].N Engl J Med,2013,369(12):1115-1123.

[8]Park D,Clare RM,Schulte PJ,et al.Extent, Location,and Clinical Significance of Non-Infarct-Related Coronary Artery Disease Among Patients With ST-Elevation Myocardial Infarction[J].JAMA,2014,312(19):2019-2027.

[9]Pieter J.Vlaar MP,Karim D,et al.Culprit Vessel Only Versus Multivessel and Staged Percutaneous Coronary Intervention for Multivessel Disease in Patients Presenting With ST-Segment Elevation Myocardial Infarction:A Pairwise and Network Meta-Analysis[J].J Am Coll Cardiol,2011,58(7):692-703.

[10]Lee JH,Park HS,Chae SC,et al.Predictors of Six-Month Major Adverse Cardiac Events in 30-Day Survivors After Acute Myocardial Infarction(from the Korea Acute Myocardial Infarction Registry)[J].Am J Cardiol,2009,104(2):182-189.

[11]Levine GN,Bates ER,Blankenship JC,et al.2015 ACC/AHA/SCAI Focused Update on Primary Percutaneous Coronary Intervention for Patients With ST-Elevation Myocardial Infarction:An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention and the 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction[J].J Am Coll Cardiol,2016,67(10):1235-1250.

[12]中华医学会心血管病学分会,中华心血管病杂志编辑委员会.急性ST段抬高型心肌梗死诊断和治疗指南[J].中华心血管病杂志,2015,43(5):380-393.

[13]Roe MT,Cura FA,Joski PS,et al.Initial Experience With Multivessel Percutaneous Coronary Intervention During Mechanical Reperfusion for Acute Myocardial Infarction[J].Am J Cardiol,2001,88(2):170-173.

[14]Corpus RA,House JA,Marso SP,et al.Multivessel percutaneous coronary intervention in patients with multivessel disease and acute myocardial infarction[J].Am Heart J,2004,148(3):493-500.

[15]Varani E,Balducelli M,Aquilina M,et al.Single or multivessel percutaneous coronary intervention in ST-elevation myocardial infarction patients[J].Catheter Cardiovasc Interv,2008,72(7):927-933.

[16]Cavender MA,Milford-Beland S,Roe MT,et al.Prevalence, Predictors, and In-Hospital Outcomes of Non-Infarct Artery Intervention During Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction(from the National Cardiovascular Data Registry)[J].Am J Cardiol,2009,104(4):507-513.

[17]Hannan EL,Samadashvili Z,Walford G,et al.Culprit Vessel Percutaneous Coronary Intervention Versus Multivessel and Staged Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction Patients With Multivessel Disease[J].JACC:Cardiovasc Interv,2010,3(1):22-31.

[18]Kim MC,Jeong MH,Park KH,et al.Three-year clinical outcomes of staged,ad hoc and culprit-only percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction and multivessel disease[J].Int J Cardiol,2014,176(2):505-507.

[19]Toma M,Buller CE,Westerhout CM,et al.Non-culprit coronary artery percutaneous coronary intervention during acute ST-segment elevation myocardial infarction:insights from the APEX-AMI trial[J].Eur Heart J,2010,31(14):1701-1707.

[20]Iqbal MB,Ilsley C,Kabir T,et al.Culprit vessel versus multivessel intervention at the time of primary percutaneous coronary intervention in patients with ST-segment-elevation myocardial infarction and multivessel disease: real-world analysis of 3984 patients in London[J].Circ Cardiovasc Qual Outcomes,2014,7(6):936-943.

[21]Gershlick AH,Khan JN,Kelly DJ,et al.Randomized trial of complete versus lesion-only revascularization in patients undergoing primary percutaneous coronary intervention for STEMI and multivessel disease:the CvLPRIT trial[J].J Am Coll Cardiol,2015,65(10):963-972.

[22]Politi L,Sgura F,Rossi R,et al.A randomised trial of target-vessel versus multi-vessel revascularisation in ST-elevation myocardial infarction:major adverse cardiac events during long-term follow-up[J].Heart,2010,96(9):662-667.

[23]Won Lee H,Hong T J,Yang MJ,et al.Comparison of infarct-related artery vs multivessel revascularization in ST-segment elevation myocardial infarction with multivessel disease:Analysis from Korea Acute Myocardial Infarction Registry[J].Cardiol J,2012,19(3):256-266.

[24]Chen HC,Tsai TH,Fang HY,et al.Benefit of revascularization in non-infarct-related artery in multivessel disease patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention[J].Int Heart J,2010,51(5):319-324.

[25]Ma LX,Lu ZH,Wang L,et al.Culprit vessel only versus“one-week” staged percutaneous coronary intervention for multivessel disease in patients presenting with ST-segment elevation myocardial infarction[J].J Geriatr Cardiol,2015,12(3):226-231.

[26]Russo JJ,Wells GA,Chong AY,et al.Safety and Efficacy of Staged Percutaneous Coronary Intervention During Index Admission for ST-Elevation Myocardial Infarction With Multivessel Coronary Disease(Insights from the University of Ottawa Heart Institute STEMI Registry)[J].Am J Cardiol,2015,116(8):1157-1162.

[27]Kornowski R,Mehran R,Dangas G,et al.Prognostic Impact of Staged Versus "One-Time" Multivessel Percutaneous Intervention in Acute Myocardial Infarction[J].J Am Coll Cardiol,2011,58(7):704-711.

[28]Tarasov RS.Six Month Results of Randomized Clinical trial: Multivessel Stenting in Primary Percutaneous Coronary Intervention and Staged Revascularization for ST-Elevation Myocardial Infarction Patients with Second Generation Drug Eluting Stents[J].Clin Med Res,2014,3(5):125-129.

[29]Kim I,Kim MC,Jeong HC,et al.Optimal Timing of Percutaneous Coronary Intervention for Nonculprit Vessel in Patients with ST-Segment Elevation Myocardial Infarction and Multivessel Disease[J].Korean Circ J,2017,47(1):36-43.

[30]Vogel B,Mehta SR,Mehran R.Reperfusion strategies in acute myocardial infarction and multivessel disease[J].Nat Rev Cardiol,2017,14(11):665-678.

[31]Bates ER,Tamis-Holland JE,Bittl JA,et al.PCI Strategies in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Coronary Artery Disease[J].J Am Coll Cardiol,2016,68(10):1066-1081.

[32]Webb JG,Sanborn TA,Sleeper LA,et al.Percutaneous coronary intervention for cardiogenic shock in the SHOCK Trial Registry[J].Am Heart J,2001,141(6):964-970.

[33]Mylotte D,Morice M,Eltchaninoff H,et al.Primary Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction, Resuscitated Cardiac Arrest, and Cardiogenic Shock[J].JACC:Cardiovasc Interv,2013,6(2):115-125.

[34]Task Force members,Windecker S,Kolh P,Alfonso F,et al.2014 ESC/EACTS Guidelines on myocardial revascularization:The Task Force on Myocardial Revascularization of the European Society of Cardiology(ESC)and the European Association for Cardio-Thoracic Surgery(EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions(EAPCI)[J].Eur Heart J,2014,35(37):2541-2619.

[35]Hu P,Tang MY,Song WC,et al.Fractional Flow Reserve Guided Percutaneous Coronary ntervention Improves Clinical Outcome with Reduced Cost in Contemporary Clinical Practice[J].Chin Med J,2015,128(15):2000-2005.

[36]Smits PC,Abdel-Wahab M,Neumann FJ,et al.Fractional Flow Reserve-Guided Multivessel Angioplasty in Myocardial Infarction[J].N Engl J Med,2017,376(13):1234-1244.

[37]Banach M,Serban C,Sahebkar A,et al.Impact of statin therapy on coronary plaque composition:a systematic review and meta-analysis of virtual histology intravascular ultrasound studies[J].BMC Medicine,2015,13(1):229.

[38]Binder RK,Maier W,Lüscher TF.Multi-vessel revascularization in ST-segment elevation myocardial infarction:where do we stand?[J].Eur Heart J,2016,37(3):217-220.

[39]Di Pasquale G,Filippini E,Pavesi PC,et al.Complete versus culprit-only revascularization in ST-elevation myocardial infarction and multivessel disease[J].Intern Emerg Med,2016,11(4):499-506.

[40]Di Mario C,Rosser G.Open questions for non-infarct-related arteries in STEMI[J].The Lancet,2015,386(9994):630-632.

[41]O’Gara PT,Kushner FG,Ascheim DD,et al.2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction[J].J Am Coll of Cardiol,2013, 61(4):e78-e140.

[42]banez B,James S,Agewall S,et al.2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation[J].Rev Esp Cardial(Engl Ed),2017,70(12):1082.

备注/Memo

备注/Memo:

收稿日期：2017-08-15.基金项目：军队“2110工程”学科建设项目教改分课题资助（院医2016-4） 通讯作者：程康，副主任医师，主要从事冠心病基础和临床研究 Email:chengkang2009@foxmail.com 共同通讯作者：韩雅玲，教授，主要从事冠心病基础和临床研究 Email:hanyaling@263.net 作者简介：许晓明，硕士生 Email:xiaomingdoc@aliyun.com

常用功能

更新日期/Last Update: 1900-01-01